Hopkins Lupus Cohort

霍普金斯狼疮队列

基本信息

  • 批准号:
    9080241
  • 负责人:
  • 金额:
    $ 69.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-10 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The Hopkins Lupus Cohort is a unique 27 year, 2300 SLE patient longitudinal cohort in which patients are followed by protocol every 3 months, allowing study of time-varying (lupus activity, cardiovascular risk factors and, treatment) variables: 1) In the last RO-1 we successfully developed and published computed tomography angiography (CTA) for detection of noncalcified plaque in SLE and showed that it was associated with same day measures of SLE activity. In this project, we will determine predictors of noncalcified plaque changes over time. We will bring an automated measure of noncalcified and calcified plaque burden to the clinic. 2) In the last RO-1 we successfully developed a consortium of U.S. sites interested in urine biomarkers of lupus nephritis activity, and discovered and published new biomarkers including urinary VCAM-1. In this project we have enlarged the consortium, arranged collaboration with the GlaxoSmithKline belimumab lupus nephritis clinical trial to obtain longitudinal samples, and have begun our own urinary proteomics discovery program. We have already successfully brought urinary TWEAK to clinical trial stage, and anticipate bringing a panel of urinary biomarkers to the clinic for identification of lupus nephrits activity and prediction of treatment outcome. 3) In a past collaboration with Biogen-Idec we found that BAFF and neutrophil gene signatures associate with same day SLE activity and predict activity over the next year. In this project, we will continue that collaboration and determine whether these gene signatures are invariant in an individual or whether they change over time. If they change, we will evaluate the contributions of treatments and other variables. These investigations will demonstrate the utility of these signatures in indicating and predicting disease activity over time, so that they can be used in the clinic and in clinical trials.
 描述(由申请人提供):霍普金斯狼疮队列是一个独特的27年、2300例SLE患者纵向队列,其中患者每3个月接受一次方案随访,允许研究随时间变化的(狼疮活动、心血管危险因素和治疗)变量:1)在上一届RO-1中,我们成功开发并发布了计算机断层扫描血管造影(CTA)用于检测SLE患者的非钙化斑块,并显示其与当天测量的SLE活动相关。在这个项目中,我们将确定非钙化斑块随时间变化的预测因子。我们将为临床带来非钙化和钙化斑块负荷的自动测量。2)在上一个RO-1中,我们成功地开发了一个对狼疮肾炎活动的尿液生物标志物感兴趣的美国网站联盟,并发现 并发表了包括尿VCAM-1在内的新生物标志物。在这个项目中,我们扩大了联盟,安排与葛兰素史克贝利木单抗狼疮肾炎临床试验合作,以获得纵向样本,并开始了我们自己的尿蛋白质组学发现计划。我们已经成功地将尿TWEAK带入临床试验阶段,并预计将一组尿生物标志物带入临床,用于识别狼疮肾炎活动和预测治疗结果。3)在过去与Biogen-Idec的合作中,我们发现BAFF和中性粒细胞基因特征与当天的SLE活动相关,并预测下一年的活动。在这个项目中,我们将继续合作,并确定这些基因签名在个体中是否不变,或者它们是否会随着时间的推移而变化。如果它们发生变化,我们将评估治疗和其他变量的贡献。这些研究将证明这些特征在指示和预测疾病活动性方面的效用,以便它们可以用于临床和临床试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHELLE A PETRI其他文献

MICHELLE A PETRI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHELLE A PETRI', 18)}}的其他基金

Hopkins Lupus Cohort
霍普金斯狼疮队列
  • 批准号:
    9768879
  • 财政年份:
    2016
  • 资助金额:
    $ 69.83万
  • 项目类别:
Hopkins Lupus Cohort
霍普金斯狼疮队列
  • 批准号:
    10000765
  • 财政年份:
    2016
  • 资助金额:
    $ 69.83万
  • 项目类别:
Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)
加速 RA 和狼疮药物合作:网络站点 (UH2/UH3)
  • 批准号:
    8851004
  • 财政年份:
    2014
  • 资助金额:
    $ 69.83万
  • 项目类别:
Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)
加速 RA 和狼疮药物合作:网络站点 (UH2/UH3)
  • 批准号:
    9323818
  • 财政年份:
    2014
  • 资助金额:
    $ 69.83万
  • 项目类别:
Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)
加速 RA 和狼疮药物合作:网络站点 (UH2/UH3)
  • 批准号:
    10200982
  • 财政年份:
    2014
  • 资助金额:
    $ 69.83万
  • 项目类别:
Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)
加速 RA 和狼疮药物合作:网络站点 (UH2/UH3)
  • 批准号:
    9240807
  • 财政年份:
    2014
  • 资助金额:
    $ 69.83万
  • 项目类别:
PROSPECTIVE LUPUS COHORT STUDY OF DISEASE ACTIVITY AND PREDICTORS OF MORBIDITY
疾病活动性和发病预测因素的前瞻性狼疮队列研究
  • 批准号:
    7604532
  • 财政年份:
    2006
  • 资助金额:
    $ 69.83万
  • 项目类别:
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
系统性红斑狼疮 (SLE)
  • 批准号:
    7604597
  • 财政年份:
    2006
  • 资助金额:
    $ 69.83万
  • 项目类别:
COGNITIVE FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
系统性红斑狼疮的认知功能
  • 批准号:
    7604703
  • 财政年份:
    2006
  • 资助金额:
    $ 69.83万
  • 项目类别:
BRAIN CONNECTIONS: ADD-ON STUDY OF SERIAL BRAIN MRIS EVERY SIX MONTHS
大脑连接:每六个月进行一次连续脑 MRI 附加研究
  • 批准号:
    7604629
  • 财政年份:
    2006
  • 资助金额:
    $ 69.83万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了